Breaking News

Recipharm Expands Testing Capabilities

New analytical lab in Bengaluru, India enhances global testing for nitrosamines, extractables and leachables, and elemental impurity testing.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Global contract development and manufacturing organization (CDMO) Recipharm has opened a new analytical lab in Bengaluru, India to enhance its global testing capabilities for nitrosamines, extractables and leachables, and elemental impurity testing. Fully cGMP/cGLP compliant, the 5,000 square foot lab will expand Recipharm’s existing analytical capabilities and provide support for biotech and pharma customers in their research and development of oral solids, drug delivery, inhalation, vaccine...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters